These findings indicate that NNMT expression may serve as a prognostic biomarker for cancer patients, albeit in a cancer-type-specific manner, as it varies between different cancer types, suggesting its potential utility in guiding prognosis and treatment decisions tailored to specific cancer contexts. The gene discussed is NNMT; the disease is cancer.